US drug prices remain excessive in part due to failure to rein in PBMs
Governments and businesses throughout the US have tried to rein in pharmacy benefit managers, but PBMs have evolved new ways around the restrictions.
United States Mark Blum Antonio Ciaccia Darrel Rowland United Health Group Optum Care Management Association
Source: dispatch.com